YBYara Backes

Yara Backes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yara Backes has a total of 145 co-authors. Here are the top co-authors by number of shared publications:

  • Leon M. G. Moons

    Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands

    11 shared publications
  • Koen Kessels

    Department of Gastroenterology and Hepatology, Flevo Hospital, Almere, The Netherlands

    6 shared publications
  • Frank P. Vleggaar

    Department of Gastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands

    5 shared publications
  • John N. Groen

    Department of Gastroenterology & Hepatology, Sint Jansdal, Harderwijk, the Netherlands

    4 shared publications
  • Marjon Kerkhof

    Department of Gastroenterology and Hepatology, Groene Hart Hospital, Gouda, The Netherlands

    4 shared publications
  • P D Siersema

    Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands

    4 shared publications

Latest Publications

  • Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study

    by Krijn J. C. Haasnoot, Yara Backes, Leon M. G. Moons, Onno Kranenburg, Anne Trinh, Louis Vermeulen, Michaël Noë, Jurriaan B. Tuynman, Anja U. G. van Lent, Rosaline van Ginneken, et al.


  • Histologic Factors Associated With Need for Surgery in Patients With Pedunculated T1 Colorectal Carcinomas

    by Yara Backes, Sjoerd G. Elias, John N. Groen, Matthijs P. Schwartz, Frank H.J. Wolfhagen, Joost M.J. Geesing, Frank ter Borg, Jeroen van Bergeijk, Bernhard W.M. Spanier, Wouter H. de Vos Tot Nederveen Cappel, et al.


  • Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study)

    by Yara Backes, Matthijs P Schwartz, Frank ter Borg, Frank H J Wolfhagen, John N Groen, Wouter H de Vos Tot Nederveen Cappel, Jeroen van Bergeijk, Joost M J Geesing, Bernhard W M Spanier, Paul Didden, et al.

    Objective This study evaluated the preresection accuracy of optical diagnosis of T1 colorectal cancer (CRC) in large non-pedunculated colorectal polyps (LNPCPs). Design In this multicentre prospective study, endoscopists predicted the histology during colonoscopy in consecutive patients with LNPCPs using a standardised procedure for optical assessment. The presence of morphological features assessed with white light, and vascular and surface pattern with narrow-band imaging (NBI) were recorded, together with the optical diagnosis, the confidence level of prediction and the recommended treatment. A risk score chart was developed and validated using a multivariable mixed effects binary logistic least absolute shrinkage and selection (LASSO) model. Results Among 343 LNPCPs, 47 cancers were found (36 T1 CRCs and 11 ≥T2 CRCs), of which 11 T1 CRCs were superficial invasive T1 CRCs (23.4% of all malignant polyps). Sensitivity and specificity for optical diagnosis of T1 CRC were 78.7% (95% CI 64.3 to 89.3) and 94.2% (95% CI 90.9 to 96.6), and 63.3% (95% CI 43.9 to 80.1) and 99.0% (95% CI 97.1 to 100.0) for optical diagnosis of endoscopically unresectable lesions (ie, ≥T1 CRC with deep invasion), respectively. A LASSO-derived model using white light and NBI features discriminated T1 CRCs from non-invasive polyps with a cross-validation area under the curve (AUC) of 0.85 (95% CI 0.80 to 0.90). This model was validated in a temporal validation set of 100 LNPCPs (AUC of 0.81; 95% CI 0.66 to 0.96). Conclusion Our study provides insights in the preresection accuracy of optical diagnosis of T1 CRC. Sensitivity is still limited, so further studies will show how the risk score chart could be improved and finally used for clinical decision making with regard to the type of endoresection to be used and whether to proceed to surgery instead of endoscopy. Trial registration number NTR5561.


  • Open Access

    Endoscopic full-thickness resection of gastric and duodenal subepithelial lesions using a new, flat-based over-the-scope clip

    by Wouter F. W. Kappelle, Yara Backes, Gerlof D. Valk, Leon M. G. Moons, Frank P. Vleggaar

    Background: Surgical resection of upper gastrointestinal (GI) subepithelial tumors (SETs) is associated with significant morbidity and mortality. A new over-the-scope (OTS) clip can be used for endoscopic full-thickness resection (eFTR). We aimed to prospectively evaluate feasibility and safety of upper GI eFTR with a new, flat-based OTS clip. Methods: Consecutive patients with a gastric or duodenal SET < 20 mm were prospectively included. After identification of the lesion, the clip was placed and lesions were resected. Patients were followed for 1 month to assess severe adverse events (SAEs); 3–6 months after eFTR, endoscopy was performed. Results: eFTR was performed on 13 lesions in 12 patients: 7 gastric and 6 duodenal SETs. Technical success was achieved in 11 cases (85%). In all 11 cases, R0-resection was achieved. In all 6 duodenal cases and in one gastric case, FTR was achieved (64%). One SAE (pain) was observed after eFTR of a gastric SET. After eFTR of duodenal SETs, several SAEs were observed: perforation (n = 1), microperforation (n = 3), and hemorrhage (n = 1). During follow-up endoscopy, the clip was no longer in situ in most patients (7 of 10; 70%). Conclusions: eFTR with this new flat-based OTS clip is feasible and effective. Although gastric eFTR was safe, eFTR in the duodenum was complicated by (micro)perforation in several patients. Therefore, the design of the clip or the technique of resection needs further refinement to improve safety of resection of SET in thin-walled areas such as the duodenum before being applied in clinical practice. Dutch trial register: NTR5023.


  • Magnifying chromoendoscopy does not seem helpful in avoiding unnecessary surgery once deep submucosal invasion is suspected

    by Yara Backes, Johannes B. Reitsma, Leon M. G. Moons

    We read with interest the article by Zhang et al. on the diagnostic accuracy of magnifying narrow-band imaging (M-NBI) for the optical diagnosis of T1 colorectal cancer (CRC) with deep submucosal invasion [1]. The authors claim that, although the specificity of M-NBI was comparable to magnifying chromoendoscopy (M-CE), the sensitivity was significantly lower (0.74, 95 % confidence interval [CI] 0.66 – 0.81 for M-NBI vs. 0.84, 95 %CI 0.76 – 0.89 for M-CE). This contradicts the conclusion of a recently published meta-analysis by our study group [2], in which no difference was observed. In this letter, we would like to discuss some concerns regarding the conclusion and recommendations proposed by Zhang et al. The authors analyzed only studies in which M-NBI was conducted, with or without subsequent M-CE. By selecting these studies, the authors actually compared M-NBI with M-NBI + M-CE, and not M-NBI with M-CE as they erroneously state. This nonblinded unidirectional order of M-CE following M-NBI does not introduce “some bias” as the authors discuss, but actually hampers them addressing their study aim. Furthermore, the conclusion of superior sensitivity for M-CE seems too firm when looking in detail at the performance of M-NBI for different subgroups. The sensitivity of M-NBI in real-time diagnosis studies (0.84, 95 %CI 0.76 – 0.89) is similar to the reported sensitivity of M-CE (0.84, 95 %CI 0.76 – 0.89), and comparable to the sensitivity of M-CE (0.81, 95 %CI 0.75 – 0.87) reported in our meta-analysis in which studies that evaluated M-CE without NBI were also included [2]. In addition, the sensitivity of M-NBI in the current review was higher when excluding abstracts that were not peer reviewed (0.76, 95 %CI 0.67 – 0.83). This obviously questions the robustness of evidence supporting the authors’ conclusion. Importantly, the authors recommend to use M-NBI first for optical diagnosis to make an endoscopic therapeutic decision, and to use M-CE when a suspected T1 CRC with deep submucosal invasion is detected, in order to re-evaluate invasion depth to avoid unnecessary surgery. This recommendation is not, however, supported by their findings, as this would require a superior specificity of M-CE (i. e. reducing false positives), which was not observed. Superior sensitivity, if present, would lower the number of false negatives. In other words, the current results do not suggest that unnecessary surgery can be avoided once deep submucosal invasion is suspected, but instead suggest that M-CE could be of value in situations where no deep submucosal invasion is suspected with M-NBI, in order to avoid unnecessary endoscopic resection of lesions with deep invasion. Taken together, both reviews demonstrate the usefulness of advanced imaging techniques, such as M-NBI and M-CE, for the optical diagnosis of deep submucosal invasion. In our opinion, the evidence is lacking that one of the techniques is superior to the other. At this moment, it therefore seems more reasonable to base the choice for a specific advanced imaging modality on local expertise, training opportunities, and available technical resources.

  • Colorectal endoscopic full-thickness resection using a novel, flat-base over-the-scope clip: a prospective study

    by Yara Backes, Wouter F. W. Kappelle, Luuk Berk, Arjun D. Koch, John N. Groen, Wouter H. de Vos Tot Nederveen Cappel, Matthijs P. Schwartz, Marjon Kerkhof, Peter D. Siersema, Roland Schröder, et al.

    Background and study aims We aimed to evaluate the feasibility and safety of a new, flat-based over-the-scope clip (Padlock Clip) for colorectal endoscopic full-thickness resection (eFTR). Patients and methods We prospectively included 26 patients with lesions < 20 mm. Indications for eFTR were re-resection of the scar of a low risk malignant polyp (n = 11), recurrent adenoma in a non-lifting scar (n = 10), non-lifting polyp (n = 4), and an adenoma located in a diverticulum (n = 1). Results Technical success rate and full-thickness resection rate were 100 % (26/26) and 92 % (24/26), respectively. Median procedure time was 43 minutes (IQR 27 – 56). No complications occurred during the procedure; 3 complications (12 %) occurred within 48 hours, of which one was a perforation requiring laparoscopic suturing. Specimen volumes from eFTR of scar tissue where the original polyp had been ≥ 20 mm (n = 13) were smaller compared with those from non-scar resections or scars where the original polyps had been < 20 mm (n = 13) (median 0.8 vs. 1.5 cm3, P = 0.03). Conclusions In this first series of colorectal eFTR using the Padlock Clip, feasibility was demonstrated. It was relatively safe in view of surgery as the alternative treatment, but could still benefit from technical refinement. Future studies should explore for which indication this technique is most suitable. Trial registration: NTR5562 (Dutch Trial Register).


  • Open Access

    The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study

    by Yara Backes, Sjoerd G. Elias, Bibie S. Bhoelan, John N. Groen, Jeroen van Bergeijk, Tom C. J. Seerden, Hendrikus J. M. Pullens, Bernhard W. M. Spanier, Joost M. J. Geesing, Koen Kessels, et al.

    In patients with stage II colorectal cancer (CRC) the number of surgically retrieved lymph nodes (LNs) is associated with prognosis, resulting in a minimum of 10–12 retrieved LNs being recommended for this stage. Current guidelines do not provide a recommendation regarding LN yield in T1 CRC. Studies evaluating LN yield in T1 CRC suggest that such high LN yields are not feasible in this early stage, and a lower LN yield might be appropriate. We aimed to validate the cut-off of 10 retrieved LNs on risk for recurrent cancer and detection of LN metastasis (LNM) in T1 CRC, and explored whether this number is feasible in clinical practice. Patients diagnosed with T1 CRC and treated with surgical resection between 2000 and 2014 in thirteen participating hospitals were selected from the Netherlands Cancer Registry. Medical records were reviewed to collect additional information. The association between LN yield and recurrence and LNM respectively were analyzed using 10 LNs as cut-off. Propensity score analysis using inverse probability weighting (IPW) was performed to adjust for clinical and histological confounding factors (i.e., age, sex, tumor location, size and morphology, presence of LNM, lymphovascular invasion, depth of submucosal invasion, and grade of differentiation). In total, 1017 patients with a median follow-up time of 49.0 months (IQR 19.6–81.5) were included. Four-hundred five patients (39.8%) had a LN yield ≥ 10. Forty-one patients (4.0%) developed recurrence. LN yield ≥ 10 was independently associated with a decreased risk for recurrence (IPW-adjusted HR 0.20; 95% CI 0.06–0.67; P = 0.009). LNM were detected in 84 patients (8.3%). LN yield ≥ 10 was independently associated with increased detection of LNM (IPW-adjusted OR 2.27; 95% CI 1.39–3.69; P = 0.001). In this retrospective observational study, retrieving < 10 LNs was associated with an increased risk of CRC recurrence, advocating the importance to perform an appropriate oncologic resection of the draining LNs and diligent LN search when patients with T1 CRC at high-risk for LNM are referred for surgical resection. Given that both gastroenterologists, surgeons and pathologists will encounter T1 CRCs with increasing frequency due to the introduction of national screening programs, awareness on the consequences of an inadequate LN retrieval is of utmost importance.


  • Mo2015 Safety and Effectiveness of Colorectal Endoscopic Full-Thickness Resection Using a New, Flat-Based Over-The-Scope Clip: A Prospective Study

    by Yara Backes, Wouter Kappelle, Luuk Berk, Arjun D. Koch, John N. Groen, Wouter de Vos Tot Nederveen Cappel, Matthijs P. Schwartz, Marjon Kerkhof, Roland Schröder, Gie Tan, et al.

  • Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study

    by Y Backes, W H de Vos Tot Nederveen Cappel, J van Bergeijk, F ter Borg, M P Schwartz, B W M Spanier, J M J Geesing, K Kessels, M Kerkhof, J N Groen, et al.

    The decision to perform secondary surgery after endoscopic resection of T1 colorectal cancer (CRC) depends on the risk of lymph node metastasis and the risk of incomplete resection. We aimed to examine the incidence and risk factors for incomplete endoscopic resection of T1 CRC after a macroscopic radical endoscopic resection. Data from patients treated between 2000 and 2014 with macroscopic complete endoscopic resection of T1 CRC were collected from 13 hospitals. Incomplete resection was defined as local recurrence at the polypectomy site during follow-up or malignant tissue in the surgically resected specimen in case secondary surgery was performed. Multivariate regression analysis was performed to analyze factors associated with incomplete resection. In total, 877 patients with a median follow-up time of 36.5 months (interquartile range 16.0-68.3) were included, in whom secondary surgery was performed in 358 patients (40.8%). Incomplete resection was observed in 30 patients (3.4%; 95% confidence interval (CI) 2.3-4.6%). Incomplete resection rate was 0.7% (95% CI 0-2.1%) in low-risk T1 CRC vs. 4.4% (95% CI 2.7-6.5%) in high-risk T1 CRC (P=0.04). Overall adverse outcome rate (incomplete resection or metastasis) was 2.1% (95% CI 0-5.0%) in low-risk T1 CRC vs. 11.7% (95% CI 8.8-14.6%) in high-risk T1 CRC (P=0.001). Piecemeal resection (adjusted odds ratio 2.60; 95% CI 1.20-5.61, P=0.02) and non-pedunculated morphology (adjusted odds ratio 2.18; 95% CI 1.01-4.70, P=0.05) were independent risk factors for incomplete resection. Among patients in whom no additional surgery was performed, who developed recurrent cancer, 41.7% (95% CI 20.8-62.5%) died as a result of recurrent cancer. In the absence of histological high-risk factors, a 'wait-and-see' policy with limited follow-up is justified. Piecemeal resection and non-pedunculated morphology are independent risk factors for incomplete endoscopic resection of T1 CRC.


  • Response to Zhang et al.

    by Y Backes, A Moss, J B Reitsma, P D Siersema, Leon M G Moons